Decisions made when designing a clinical trial protocol can have significant downstream financial impacts during product development and commercialization. These critical study design decisions can influence clinical trial performance in many ways, including the quantity of protocol amendments, ability to recruit and retain patients, and the overall timeline of the development program. Fortunately, with access to the right data, decision making during protocol authoring can now be insights-driven instead of high-risk predictions.
In this session, industry experts will discuss the challenges encountered in study design and protocol development while presenting concrete approaches and strategies to minimize risks, improve decision-making, and get the protocol design right the first time.
https://vshow.on24.com/vshow/WatsonHealth2020/content/2427835
Clinical development
Webinar